Regulus Therapeutics Inc.
RGLSDelisted Jun 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001505512
Regulus Therapeutics Inc. was delisted on Jun 25, 2025; its insiders filed their last Form 4 on Jun 27, 2025; 75 institutions reported holding it in 13F filings for Q1 2025, worth $107.0M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Regulus Therapeutics Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 38 | 1 | 37 | 0 |
| Shares | 30.2M | 2.73M | 60.7M | +33.2M (+121.1%) |
| Value | $9.54M | $860.0K | $18.1M | +$9.40M (+108.3%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Regulus Therapeutics Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Federated Hermes, Inc. | 29,048,265 | $8.66M | 0.02% |
| Susquehanna International Group, LLP | 65,825 | $20.0K | 0.00% |
| Millennium Management LLC | 48,886 | $15.0K | 0.00% |
Sold out (3)
Institutions that held Regulus Therapeutics Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Empery Asset Management, LP | 5,074,251 | $1.60M |
| Morgan Stanley | 6,000 | $2.00K |
| Simplex Trading, LLC | 1,049 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Regulus Therapeutics Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Asymmetry Capital Management, L.P. | 2,731,044 | $860.0K |